ArticleStatistics in biosciences2026
Contrastive Latent Functional Model.
Article in Statistics in biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Functional Principal Component Analysis (FPCA) is a popular tool for representing functional data in lower-dimensions, along highly-interpretable components depicting directions of variation in the data across time. We extend FPCA to contrastive settings involving multiple groups with a focus on time-dynamic components which are shared across samples versus those that are unique to a particular sample. The proposed Contrastive Latent Functional Model (cLFM) integrates FPCA with contrastive learning principles to capture common directions of variation across datasets while isolating distinct features specific to each sample. The model employs a computationally efficient Expectation-Maximization (EM) algorithm for parameter estimation, ensuring orthogonality between shared and unique functional spaces. Simulation studies demonstrate the efficacy of the proposed method across different scenarios of shared and unique variation, varying sample size and error variance. Applied to neurodevelopmental and clinical datasets, including EEG studies and longitudinal studies of kidney function, cLFM reveals novel insights into group differences between autism vs neurotypical development and among mild to severe albuminuria subgroups of chronic kidney disease patients. Bridging contrastive analysis with functional data, this framework advances the capacity to disentangle complex variation patterns in multi-group functional studies in biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.